Results 61 to 70 of about 8,796 (159)

Radiolabeled Somatostatin Analogs-A Continuously Evolving Class of Radiopharmaceuticals. [PDF]

Cancers (Basel), 2022
Fani M, Mansi R, Nicolas GP, Wild D.
europepmc   +1 more source

Resistance to Somatostatin Analogs in Italian Acromegaly Patients: The MISS Study. [PDF]

J Clin Med, 2022
Berton AM, Prencipe N, Bertero L, Baldi M, Bima C, Corsico M, Bianchi A, Mantovani G, Ferraù F, Sartorato P, Gagliardi I, Ghigo E, Grottoli S.   +12 more
europepmc   +1 more source

Prescription patterns of somatostatin analogs in patients with acromegaly and neuroendocrine tumors. [PDF]

J Endocrinol Invest, 2023
Machado-Alba JE, Machado-Duque ME, Gaviria-Mendoza A, Arsof-Saab IN, Castellanos-Moreno CA, Botero L, Triana L.   +6 more
europepmc   +1 more source

Editorial: Toward Prognostic Precision in the Management of Gastroenteropancreatic Neuroendocrine Neoplasms

Cancer Control
Gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs), which encompass well-differentiated neuroendocrine tumors (NETs) and poorly differentiated neuroendocrine carcinomas (NECs), are a clinically and pathologically heterogeneous group of diseases ...
Muhammer Ergenç MD, FEBS, Hilmi Yazıcı MD   +1 more
doaj   +1 more source

Long-term use of somatostatin analogs for chronic gastrointestinal bleeding in hereditary hemorrhagic telangiectasia. [PDF]

Front Med (Lausanne), 2023
Torres-Iglesias R, Mora-Luján JM, Iriarte A, Cerdà P, Alba E, Sánchez-Corral MÁ, Berrozpe A, Cruellas F, Gamundí E, Ribas J, Castellote J, Riera-Mestre A.   +11 more
europepmc   +1 more source

The Role of Somatostatin in the Gastrointestinal Tract

Biology
The gastrointestinal (GI) tract is responsible for food digestion and host protection from harmful stimuli; however, its function as an endocrine organ is also well documented. Somatostatin (SST) was first discovered in the hypothalamus, but the GI tract
Konstantinos Papantoniou, Ioanna Aggeletopoulou, Ploutarchos Pastras, Christos Triantos   +3 more
doaj   +1 more source

Evaluating home injection compared with healthcare-setting injection of somatostatin analogs: a systematic literature review. [PDF]

Endocrine, 2023
Boguszewski CL, Korbonits M, Artignan A, García AM, Houchard A, Ribeiro-Oliveira A, de Herder WW.   +6 more
europepmc   +1 more source

Comparing Somatostatin Analogs in the Treatment of Advanced Gastroenteropancreatic Neuroendocrine Tumors. [PDF]

Oncology, 2022
Allaw MB, Switchenko JM, Khalil L, Wu C, Alese OB, Akce M, Draper A, Jones AT, El-Rayes B, Shaib W.   +9 more
europepmc   +1 more source

A Real-World Observational Study of the Use and Associated Costs of Treating Neuroendocrine Tumors With Somatostatin Analogs in Canada. [PDF]

Pancreas, 2022
Cheung WY, LaForty C, Liovas A, McKechnie H, Loree JM.   +4 more
europepmc   +1 more source

Efficacy of cabergoline add-on therapy in patients with acromegaly resistance to somatostatin analogs treatment and the review of literature. [PDF]

Arch Endocrinol Metab, 2022
Kizilgul M, Duger H, Nasiroglu NI, Sencar E, Hepsen S, Akhanli P, Berker D, Cakal E, Bostan H, Ucan B.   +9 more
europepmc   +1 more source